Retracted: Immunotherapy of metastatic breast cancer patients with vitamin D-binding protein-derived macrophage activating factor (GcMAF)

Authors

  • Nobuto Yamamoto,

    Corresponding author
    1. Division of Cancer Immunology and Molecular Biology, Socrates Institute for Therapeutic Immunology, Philadelphia, PA 19126-3305
    • Division of Cancer and Molecular Immunology, Socrates Institute for Therapeutic Immunology, 1040 66th Ave, Philadelphia, PA 19126-3305, USA===

    Search for more papers by this author
    • Fax: +215-424-1850

  • Hirofumi Suyama,

    1. Nagasaki Immunotherapy Research Group, Nagasaki, Japan 850-806
    Search for more papers by this author
  • Nobuyuki Yamamoto,

    1. Division of Cancer Immunology and Molecular Biology, Socrates Institute for Therapeutic Immunology, Philadelphia, PA 19126-3305
    Search for more papers by this author
  • Naofumi Ushijima

    1. Division of Cancer Immunology and Molecular Biology, Socrates Institute for Therapeutic Immunology, Philadelphia, PA 19126-3305
    Search for more papers by this author

Errata

This article is corrected by:

  1. Errata: Retraction Volume 135, Issue 6, 1509, Article first published online: 7 July 2014

Abstract

The above article from the International Journal of Cancer, published online on 12 October 2007 in Wiley Online Library and in Volume 122, Issue 2, pp 461–467, has been retracted by agreement between the journal Editor-in-Chief Peter Lichter and Wiley Periodicals, Inc. due to irregularities in the documentation for institutional review board approval.

Ancillary